Close

BioNTech (BNTX) Upcoming COVID-19 Vaccine Data Seen as 'Differentiated' - BofA Securities

August 20, 2020 8:23 AM EDT Send to a Friend
Tazeen Ahmad, an analyst at BofA Securities, believes that BioNTech's (NASDAQ: BNTX) COVID-19 vaccine candidate, developed together with Pfizer (NYSE ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login